Crossmark

Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator

Published Online: 2016-01-18

Authors

Yin, Tao

Wang, Guoping

Ye, Tinghong

Wang, Yongsheng
License Information

Text and Data Mining valid from 2016-01-18

Version of Record valid from 2016-01-18
More Information

Article History

Received: 9 October 2015

Accepted: 14 December 2015

First Online: 18 January 2016

Competing interests

: The authors declare no competing financial interests.

Document is current